Open Access

ARTICLE

Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients

JUAN SHEN^1,#, WEIYU ZHANG^2,3,#, QINQIN JIN^2,3,#, FUYU GONG^4,#, HEPING ZHANG⁵, HONGLIANG XU⁵, JIEJIE LI^2,3, HUI YAO^2,3, XIYA JIANG^2,3, YINTING YANG^2,3, LIN HONG^2,3, JIE MEI^2,3, YANG SONG^6,*, SHUGUANG ZHOU^2,3,7,*

1 School of Big Data and Artificial Intelligence, Anhui Xinhua University, Hefei, 230088, China
2 Department of Gynecology and Obstetrics, Maternity and Child Healthcare Hospital Affiliated to Anhui Medical University, Anhui Province Maternity and Child Healthcare Hospital, Hefei, 230001, China
3 Department of Gynecology and Obstetrics, The Fifth Clinical College of Anhui Medical University, Hefei, 230032, China
4 Departments of Breast Surgery, Fuyang Women and Children’s Hospital, Fuyang, 236000, China
5 Departments of Pathology, Anhui Province Maternity and Child Health Hospital, Hefei, 230001, China
6 Department of Pain, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China
7 Department of Gynecology and Obstetrics, Linquan Maternity and Child Healthcare Hospital, Fuyang, 236400, China

* Corresponding Authors: YANG SONG. Email: ; SHUGUANG ZHOU. Email:
# These authors contributed equally